CAS: 201605-51-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 1-Naphthalenepropanoic acid, β-[2-[[2-(8-azaspiro[4.5]dec-8-ylcarbonyl)-4,6-dimethylphenyl]amino]-2-oxoethyl]-, (βR)- REF: IN-DA002DJ5CAS: 201605-51-8 | - - - | To inquire | Wed 04 Dec 24 |
 | Itriglumide REF: TM-T27640CAS: 201605-51-8 | 99.95% | 272.00 €~1,836.00 € | Wed 22 Jan 25 |
![1-Naphthalenepropanoic acid, β-[2-[[2-(8-azaspiro[4.5]dec-8-ylcarbonyl)-4,6-dimethylphenyl]amino]-…](https://static.cymitquimica.com/products/IN/thumb/DA002DJ5.jpg)
1-Naphthalenepropanoic acid, β-[2-[[2-(8-azaspiro[4.5]dec-8-ylcarbonyl)-4,6-dimethylphenyl]amino]-2-oxoethyl]-, (βR)-
CAS:201605-51-8
Formula:
C33H38N2O4
Molecular weight:
526.6658
Ref: IN-DA002DJ5
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Itriglumide
CAS:201605-51-8
Itriglumide, a CCK2 receptor antagonist, is used potentially for the treatment of peptic ulcers, dyspepsia, …
Formula:
C33H38N2O4
Purity:
99.95%
Color and Shape:
Solid
Molecular weight:
526.67
Ref: TM-T27640
| 1mg | 272.00 € | ||
| 2mg | 405.00 € | ||
| 5mg | 670.00 € | ||
| 10mg | 915.00 € | ||
| 25mg | 1,409.00 € | ||
| 50mg | 1,836.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
